This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koch, P. Articles by Dobbelstein, M. Search for Related Content PubMed PubMed Citation Articles by Koch, P. Articles by Dobbelstein, M.

Efficient Replication of Adenovirus Despite the Overexpression of Active and Nondegradable p53¹

Institut für Virologie, Philipps-Universität Marburg, 35037 Marburg [P. K., J. G., C. L., U. H., C. L-S., M. D.], and Abteilung für Gastroenterologie und Stoffwechsel, Klinikum der Philipps-Universität Marburg, 35043 Marburg [J. R.], Germany

The adenoviral oncoproteins E1B-55 kDa and E4orf6 inactivate and destabilize the tumor suppressor protein p53, thereby contributing to malignant transformation. However, it is unclear whether the elimination of p53 also contributes to the efficiency of viral replication. Furthermore, it is controversial whether adenoviruses with a deletion in the E1B-55 kDa-coding region might selectively replicate in cells with a mutation or deletion of the p53 gene and, therefore, represent a tool in cancer therapy. To address the role of p53 in virus replication, amino acid substitutions were introduced into the NH₂-terminal portion of p53, replacing residues 24–28 with the corresponding sequence of the human p53-homologue p73. This replacement leaves p53 transcriptionally active but renders the modified protein, termed p53mt24-28, completely resistant to inhibition and degradation by adenoviral oncoproteins. Surprisingly, even strong overexpression of p53 or p53mt24-28 allowed the virus to replicate as efficiently as in the absence of p53 proteins, both in tumor cells and in primary endothelial cells. Also, p53 or p53mt24-28 did not reduce the amount of virus released from infected cells. These observations were made in primary cells or in cell lines that were capable of expressing the p53-agonist p14ARF. Thus, active p53 does not inhibit the growth of adenovirus. Alternative strategies should be used to improve the utility of adenoviruses in cancer therapy.

This article has been cited by other articles:

				E. Gurlevik, N. Woller, P. Schache, N. P. Malek, T. C. Wirth, L. Zender, M. P. Manns, S. Kubicka, and F. Kuhnel p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication Nucleic Acids Res., May 14, 2009; (2009) gkp374v1. [Abstract] [Full Text] [PDF]

				A. N. Blackford and R. J. A. Grand Adenovirus E1B 55-Kilodalton Protein: Multiple Roles in Viral Infection and Cell Transformation J. Virol., May 1, 2009; 83(9): 4000 - 4012. [Full Text] [PDF]

				G. P. Horn, S. Vongpunsawad, E. Kornmann, B. Fritz, D. P. Dittmer, R. Cattaneo, and M. Dobbelstein Enhanced Cytotoxicity without Internuclear Spread of Adenovirus upon Cell Fusion by Measles Virus Glycoproteins J. Virol., February 1, 2005; 79(3): 1911 - 1917. [Abstract] [Full Text] [PDF]

				M. A. I. Abou El Hassan, I. van der Meulen-Muileman, S. Abbas, and F. A. E. Kruyt Conditionally Replicating Adenoviruses Kill Tumor Cells via a Basic Apoptotic Machinery-Independent Mechanism That Resembles Necrosis-Like Programmed Cell Death J. Virol., November 15, 2004; 78(22): 12243 - 12251. [Abstract] [Full Text] [PDF]

				U. Hobom and M. Dobbelstein E1B-55-Kilodalton Protein Is Not Required To Block p53-Induced Transcription during Adenovirus Infection J. Virol., July 15, 2004; 78(14): 7685 - 7697. [Abstract] [Full Text] [PDF]

				K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein p21/CDKN1A Mediates Negative Regulation of Transcription by p53 J. Biol. Chem., August 29, 2003; 278(35): 32507 - 32516. [Abstract] [Full Text] [PDF]

				K. Lohr, O. Hartmann, H. Schafer, and M. Dobbelstein Mutual Interference of Adenovirus Infection and myc Expression J. Virol., July 15, 2003; 77(14): 7936 - 7944. [Abstract] [Full Text] [PDF]

				J. Roth, C. Lenz-Bauer, A. Contente, K. Lohr, P. Koch, S. Bernard, and M. Dobbelstein Reactivation of Mutant p53 by a One-Hybrid Adaptor Protein Cancer Res., July 15, 2003; 63(14): 3904 - 3908. [Abstract] [Full Text] [PDF]

				A. Contente, H. Zischler, A. Einspanier, and M. Dobbelstein A Promoter that Acquired p53 Responsiveness During Primate Evolution Cancer Res., April 15, 2003; 63(8): 1756 - 1758. [Abstract] [Full Text] [PDF]

				V. W. van Beusechem, P. B. van den Doel, J. Grill, H. M. Pinedo, and W. R. Gerritsen Conditionally Replicative Adenovirus Expressing p53 Exhibits Enhanced Oncolytic Potency Cancer Res., November 1, 2002; 62(21): 6165 - 6171. [Abstract] [Full Text] [PDF]

				C. Lober, C. Lenz-Stoppler, and M. Dobbelstein Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53 J. Gen. Virol., August 1, 2002; 83(8): 2047 - 2057. [Abstract] [Full Text] [PDF]

				Y. S. Haviv, K. Takayama, J. N. Glasgow, J. L. Blackwell, M. Wang, X. Lei, and D. T. Curiel A Model System for the Design of Armed Replicating Adenoviruses Using p53 as a Candidate Transgene Mol. Cancer Ther., March 1, 2002; 1(5): 321 - 328. [Abstract] [Full Text] [PDF]